Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07069556
ColoSense Post-Approval Study
Sponsor: Geneoscopy, Inc.
View on ClinicalTrials.gov
Summary
The post-approval study (PAS) described here will supplement existing data generated in the CRC-PREVENT clinical trial. The primary outcomes of this supplemental study will include: clinical sensitivity, clinical specificity, positive predictive value (PPV), and negative predictive value (NPV) of ColoSense.
Official title: ColoSense Post Approval Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
12500
Start Date
2025-09-05
Completion Date
2030-09-01
Last Updated
2025-11-21
Healthy Volunteers
Yes
Conditions
Interventions
DEVICE
ColoSense
multi-target stool RNA test
Locations (1)
Decentralized Study
St Louis, Missouri, United States